Uzm. Dr. Burcu Gülbağcı

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

Immunotherapy, 2026

DOI 10.1080/1750743x.2026.2722548 PMID 42683510 Texte intégral en libre accèsSource : OpenAlex

Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

Cancers, 2026

DOI 10.3390/cancers18030394 PMID 41681877 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

Cancers, 2026

DOI 10.3390/cancers18142302 PMID 42512369 Texte intégral en libre accèsSource : ORCID

Short-Term Biceps Muscle Wasting Assessed by Serial Ultrasound as a Predictor of Survival Duration in Terminally Ill Cancer Patients: A Retrospective Cohort Study

Medicina, 2026

DOI 10.3390/medicina62020292 PMID 41752691 Texte intégral en libre accèsSource : ORCID

AGGF-1 Expression as a Predictive Biomarker for Anti-VEGF Therapy in Metastatic Colorectal Cancer

Eurasian Journal of Medical Investigation, 2026

DOI 10.14744/ejmi.263054 Source : OpenAlex

Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.

BMC cancer, 2026

DOI 10.1186/s12885-026-16210-z PMID 42192342 Texte intégral en libre accèsSource : ORCID

Relationship Between Netrin-1 Staining and Neoadjuvant Treatment Response in HER2-Positive Locally Advanced Breast Cancer

Cancer management and research, 2026

DOI 10.2147/cmar.s551516 PMID 41710041 Texte intégral en libre accèsSource : Europe PMC

Investigating the FIB-4 index and PET/CT metabolic parameters for the differentiation status of hepatocellular carcinoma

The Annals of Clinical and Analytical Medicine, 2026

DOI 10.4328/acam.50067 Texte intégral en libre accèsSource : OpenAlex

Global research trends and intellectual structure of immune checkpoint inhibitor–associated pneumonitis: a bibliometric analysis (2000–2025

Journal of Medicine and Palliative Care, 2026

DOI 10.47582/jompac.1900478 Texte intégral en libre accèsSource : OpenAlex

Association between serum preptin levels and bone metastasis in newly diagnosed prostate cancer: a prospective exploratory study

Journal of bone oncology, 2026

DOI 10.1016/j.jbo.2026.100794 PMID 42656999 Texte intégral en libre accèsSource : OpenAlex

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

Future Oncology, 2025

DOI 10.1080/14796694.2025.2570637 PMID 41103123 Texte intégral en libre accèsSource : OpenAlex

Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Clinical Breast Cancer, 2025

DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

Turkish Journal of Clinics and Laboratory, 2025

DOI 10.18663/tjcl.1639022 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Real-world treatment patterns and prognostic indicators in upper tract urothelial carcinoma: A Turkish Oncology Group (TOG) study

European Urology Open Science, 2025

DOI 10.1016/s2666-1683(25)01751-3 Texte intégral en libre accèsSource : OpenAlex

Does toxicity of cyclin-dependent kinase 4/6 inhibitor predict treatment response in metastatic hormone-positive breast cancer patients?

Oncology in Clinical Practice, 2025

DOI 10.5603/ocp.101970 Texte intégral en libre accèsSource : OpenAlex

Prognostic Significance of HALP Score in Second-Line Nivolumab Treatment of Advanced Non-Small Cell Lung Cancer

Namık Kemal Tıp Dergisi, 2025

DOI 10.4274/nkmj.galenos.2024.76093 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

BMC Cancer, 2024

DOI 10.1186/s12885-024-13357-5 PMID 39736618 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

223P Real-world treatment efficacy of ribociclib or palbociclib plus fulvestrant in hormone receptor-positive/HER2-negative metastatic breast cancer: Turkish Oncology Group (TOG) study

ESMO Open, 2024

DOI 10.1016/j.esmoop.2024.103245 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Can Serum Albumin Level At Diagnosis Be A Guide for Clinical Features, Time to Treatment, and Response in Patients with Follicular Lymphoma?

Namık Kemal Tıp Dergisi, 2024

DOI 10.4274/nkmj.galenos.2024.35002 Texte intégral en libre accèsSource : OpenAlex

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

Scientific Reports, 2024

DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Gustave Roussy immune score is an independent prognostic factor for treatment response and survival in advanced non-small cell lung cancer treated with nivolumab at second-line therapy

Oncology in Clinical Practice, 2024

DOI 10.5603/ocp.101103 Texte intégral en libre accèsSource : OpenAlex

Major and minor salivary gland cancers: A multicenter retrospective study

Head & Neck, 2023

DOI 10.1002/hed.27376 PMID 37084179 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Future Oncology, 2023

DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

252P Impact of HER2 expression levels on survival in patients with hormone receptor positive and HER2 negative advanced breast cancer and treated with ribociclib and palbociclib in combination with endocrine therapy: A real-life data, Turkish Oncology Group study

ESMO Open, 2023

DOI 10.1016/j.esmoop.2023.101440 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

Medicine, 2023

DOI 10.1097/md.0000000000035950 PMID 37960746 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Comparison of immunogenicity for Sinovac-CoronaVac vaccine vs. natural infection during cancer treatment.

PubMed, 2023

DOI 10.26355/eurrev_202305_32341 PMID 37203857 Source : OpenAlex

Temel Onkoloji

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1765 Source : OpenAlex

Paraneoplastik Sendromlar

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1826 Texte intégral en libre accèsSource : ORCID

The role of neutrophil albumin ratio in predicting the stage of non-small cell lung cancer.

PubMed, 2022

DOI 10.26355/eurrev_202204_28621 PMID 35503633 17 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Jinekolojik Tümörler ve Paraneoplastik Sendromlar

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.1826.c17413 Source : OpenAlex

Onkolojik Aciller

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.352 Source : ORCID

Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer

Scientific Reports, 2021

DOI 10.1038/s41598-021-93659-x PMID 34239026 12 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

COVID-19 prevalence and oncologic outcomes of asymptomatic patients with active cancer who received chemotherapy

Sakarya Üniversitesi Kurumsal Açık Akademik Arşivi, 2021

DOI 10.19193/0393-6384_2021_1_103 3 citations (OpenAlex) Source : OpenAlex

Has the COVID-19 Pandemic Increased Mortality Among Patients with Cancer Receiving Systemic Anticancer Treatments?

Journal of College of Physicians And Surgeons Pakistan, 2021

DOI 10.29271/jcpsp.2021.01.s66 PMID 33650412 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Evaluation of the relationship of disease activity with neutrophile to lymphocyte ratio and platelet to lymphocyte ratio in patients with peptic ulcer and gastritis

International Journal of Research in Medical Sciences, 2020

DOI 10.18203/2320-6012.ijrms20204869 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Sakarya Üniversitesi Tıbbi Onkoloji Kliniği 2017-2018 Yılı Akciğer Kanseri İstatistikleri

DergiPark (Istanbul University), 2020

Texte intégral en libre accèsSource : OpenAlex